Patients with migraine may be willing to trade off efficacy for better adverse event profiles.
From the Journals
“Clinicians can address this gap by regularly prescribing naloxone to eligible patients.”
MILWAUKEE – Pain and substance use issues are frequently comorbid in the military health population.
Medical cannabis was an effective and well-tolerated treatment in an elderly cohort of patients with chronic pain.
News from the FDA/CDC
Officials at the Centers for Disease Control and Prevention are advising against misapplication of the agency’s guideline on opioid prescribing....
MILWAUKEE – Brief cognitive-behavioral therapy holds promise to restore functional connectivity disrupted by pain and catastrophizing.
PHILADELPHIA – In a field plagued by “squishy” data, standouts include neuropathic pain, nausea, spasticity, and...
PHILADELPHIA – More head-to-head trials of treatments for neuropathic pain are needed.
MILWAUKEE – Objective smartphone-based testing tracked with subjective assessment of cognitive function in fibromyalgia.
The label changes are intended to be used when both the clinician and patient have agreed to reduce the opioid dosage.
MILWAUKEE – The two aims of research under the initiative are to improve treatments for misuse and addiction, and to enhance pain management.